Page 48 - Read Online

Page 6 of 7 Lo. Hepatoma Res 2019;5:41 I http://dx.doi.org/10.20517/2394-5079.2019.021

carcinoma. Clin Cancer Res 2019;25:5859-65.
8. Calderaro J, Couchy G, Imbeaud S, Amaddeo G, Letouze E, et al. Histological subtypes of hepatocellular carcinoma are related to
gene mutations and molecular tumour classification. J Hepatol 2017;67:727-38.
9. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, et al. Transcriptome classification of HCC is related to gene
alterations and to new therapeutic targets. Hepatology 2007;45:42-52.
10. Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive
histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Am J Surg Pathol 2010;34:1630-6.
11. Salomao M, Remotti H, Vaughan R, Siegel AB, Lefkowitch JH, et al. The steatohepatitic variant of hepatocellular carcinoma and its
association with underlying steatohepatitis. Hum Pathol 2012;43:737-46.
12. Tan PS, Nakagawa S, Goossens N, Venkatesh A, Huang T, et al. Clinicopathological indices to predict hepatocellular carcinoma
molecular classification. Liver Int 2016;36:108-18.
13. Jain D, Nayak NC, Kumaran V, Saigal S. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic
risk factors: a study from India. Arch Pathol Lab Med 2013;137:961-6.
14. Lee JS, Yoo JE, Kim H, Rhee H, Koh MJ, et al. Tumor stroma with senescence-associated secretory phenotype in steatohepatitic
hepatocellular carcinoma. PLoS One 2017;12:e0171922.
15. Yeh MM, Liu Y, Torbenson M. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or
background steatosis: a clinical, pathological, and genetic study. Hum Pathol 2015;46:1769-75.
16. Taniai M, Hashimoto E, Tobari M, Kodama K, Tokushige K, et al. Clinicopathological investigation of steatohepatitic hepatocellular
carcinoma: a multicenter study using immunohistochemical analysis of adenoma-related markers. Hepatol Res 2018;48:947-55.
17. Ando S, Shibahara J, Hayashi A, Fukayama M. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features:
immunohistochemical and mutational study. Virchows Arch 2015;467:535-42.
18. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, et al. Integrative transcriptome analysis reveals common molecular
subclasses of human hepatocellular carcinoma. Cancer Res 2009;69:7385-92.
19. Chan AW, Tong JH, Pan Y, Chan SL, Wong GL, et al. Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of
hepatocellular carcinoma with favorable outcome. Am J Surg Pathol 2015;39:304-12.
20. Patel KR, Liu TC, Vaccharajani N, Chapman WC, Brunt EM. Characterization of inflammatory (lymphoepithelioma-like)
hepatocellular carcinoma: a study of 8 cases. Arch Pathol Lab Med 2014;138:1193-202.
21. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic
infiltration. Hepatology 1998;27:407-14.
22. Chen CJ, Jeng LB, Huang SF. Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J 2007;30:172-7.
23. Cacciato Insilla A, Faviana P, Pollina LE, De Simone P, Coletti L, et al. Lymphoepithelioma-like hepatocellular carcinoma: case report
and review of the literature. World J Gastroenterol 2015;21:10468-74.
24. Shinoda M, Kadota Y, Tsujikawa H, Masugi Y, Itano O, et al. Lymphoepithelioma-like hepatocellular carcinoma: a case report and a
review of the literature. World J Surg Oncol 2013;11:97.
25. Park HS, Jang KY, Kim YK, Cho BH, Moon WS. Hepatocellular carcinoma with massive lymphoid infiltration: a regressing
phenomenon? Pathol Res Pract 2009;205:648-52.
26. Si MW, Thorson JA, Lauwers GY, DalCin P, Furman J. Hepatocellular lymphoepithelioma-like carcinoma associated with epstein barr
virus: a hitherto unrecognized entity. Diagn Mol Pathol 2004;13:183-9.
27. Shirabe K, Matsumata T, Maeda T, Sadanaga N, Kuwano H, et al. A long-term surviving patient with hepatocellular carcinoma
including lymphocytes infiltration - a clinicopathological study. Hepatogastroenterology 1995;42:996-1001.
28. Emile JF, Adam R, Sebagh M, Marchadier E, Falissard B, et al. Hepatocellular carcinoma with lymphoid stroma: a tumour with good
prognosis after liver transplantation. Histopathology 2000;37:523-9.
29. Wei J, Liu Q, Wang C, Yu S. Lymphoepithelioma-like hepatocellular carcinoma without Epstein-Barr virus infection: a case report and
a review of the literature. Indian J Pathol Microbiol 2015;58:550-3.
30. An SL, Liu LG, Zheng YL, Rong WQ, Wu F, et al. Primary lymphoepithelioma-like hepatocellular carcinoma: report of a locally
advanced case and review of literature. Int J Clin Exp Pathol 2015;8:3282-7.
31. Labgaa I, Stueck A, Ward SC. Lymphoepithelioma-like carcinoma in liver. Am J Pathol 2017;187:1438-44.
32. Chan AW, Zhang Z, Chong CC, Tin EK, Chow C, et al. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma. J
Pathol 2019;249:166-72.
33. Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, et al. Prospective genotyping of hepatocellular carcinoma: clinical
implications of next-generation sequencing for matching patients to targeted and immune therapies. Clin Cancer Res 2019;25:2116-26.
34. Calderaro J, Rousseau B, Amaddeo G, Mercey M, Charpy C, et al. Programmed death ligand 1 expression in hepatocellular carcinoma:
relationship with clinical and pathological features. Hepatology 2016;64:2038-46.
35. Seok JY, Na DC, Woo HG, Roncalli M, Kwon SM, et al. A fibrous stromal component in hepatocellular carcinoma reveals a
cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology 2012;55:1776-86.
36. Farooq A, Merath K, Paredes AZ, Wu L, Tsilimigras DI, et al. Outcomes of patients with scirrhous hepatocellular carcinoma: insights
from the national cancer database. J Gastrointest Surg 2019; Epub ahead of print [DOI: 10.1007/s11605-019-04282-1]
37. Lee JH, Choi MS, Gwak GY, Lee JH, Koh KC, et al. Clinicopathologic characteristics and long-term prognosis of scirrhous
hepatocellular carcinoma. Dig Dis Sci 2012;57:1698-707.
38. Fujii T, Zen Y, Harada K, Niwa H, Masuda S, et al. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous
hepatocellular carcinoma - human and cell culture study. Hum Pathol 2008;39:1185-96.
39. Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, et al. Cellular and stromal characteristics in the scirrhous hepatocellular
carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int 2005;55:724-31.